TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T09177 XX ID T09177 XX DT 02.08.2006 (created); man. DT 24.12.2014 (updated); pro. CO Copyright (C), QIAGEN. XX FA MyoD XX SY MEF1; Myoblast determination protein 1; MyoD; MyoD1. XX OS mouse, Mus musculus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX GE G000576 Myod1. XX CL C0010; bHLH. XX SZ 318 AA; 34.2 kDa (cDNA) (calc.), 45 kDa (SDS) XX SQ MELLSPPLRDIDLTGPDGSLCSFETADDFYDDPCFDSPDLRFFEDLDPRLVHVGALLKPE SQ EHAHFSTAVHPGPGAREDEHVRAPSGHHQAGRCLLWACKACKRKTTNADRRKAATMRERR SQ RLSKVNEAFETLKRCTSSNPNQRLPKVEILRNAIRYIEGLQALLRDQDAAPPGAAAFYAP SQ GPLPPGRGSEHYSGDSDASSPRSNCSDGMMDYSGPPSGPRRQNGYDTAYYSEAVRESRPG SQ KSAAVSSLDCLSSIVERISTDSPAAPALLLADAPPESPPGPPEGASLSDTEQGTQTPSPD SQ AAPQCPAGSNPNAIYQVL XX SC Swiss-Prot#P10085 XX FT 1 109 PF01586; Myogenic Basic domain. FT 1 114 SM00520; BASIC. FT 100 112 nuclear localization signal (NLS234) [48]. FT 109 161 PS50888; HLH. FT 110 161 PF00010; Helix-loop-helix DNA-binding domain. FT 115 166 SM00353; finulus. FT 130 135 nuclear localization signal (NLS6) [48]. FT 146 146 important for DNA binding [55]. XX IN T00204 E12; human, Homo sapiens. IN T05421 E47; golden (Syrian) hamster, Mesocricetus auratus. IN T00403 Id1; mouse, Mus musculus. IN T10004 Id2; mouse, Mus musculus. IN T09198 Id3; mouse, Mus musculus. IN T10381 ipf1; golden (Syrian) hamster, Mesocricetus auratus. IN T09177 MyoD; mouse, Mus musculus. XX MX M00804 V$E2A_Q2. MX M00973 V$E2A_Q6. MX M01034 V$EBOX_Q6_01. MX M00001 V$MYOD_01. MX M00184 V$MYOD_Q6. MX M00929 V$MYOD_Q6_01. MX M02100 V$MYOD_Q6_02. XX BS R41839. BS R03109. BS R00012. BS R00014. BS R04467. BS R20591. BS R20592. BS R20593. BS R20595. BS R20596. BS R04020. BS R04021. BS R04418. BS R65461. BS R00242. BS R26341. BS R14856. BS R14857. BS R14858. BS R29572. BS R02898. XX DR TRANSPATH: MO000084139. DR EMBL: M18779; DR EMBL: X61655; DR UniProtKB: P10085; DR PDB: 1mdy. XX RN [1]; RE0000052. RX PUBMED: 2550138. RA Lassar A. B., Buskin J. N., Lockshon D., Davis R. L., Apone S., Hauschka S. D., Weintraub H. RT MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer RL Cell 58:823-831 (1989). RN [2]; RE0000053. RX PUBMED: 2503252. RA Murre C., McCaw P. S., Vaessin H., Caudy M., Jan L. Y., Jan Y. N., Cabrera C. V., Buskin J. N., Hauschka S. D., Lassar A. B., Weintraub H., Baltimore D. RT Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence RL Cell 58:537-544 (1989). RN [3]; RE0000054. RX PUBMED: 2155707. RA Davis R. L., Cheng P.-F., Lassar A. B., Weintraub H. RT The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation RL Cell 60:733-746 (1990). RN [4]; RE0000092. RX PUBMED: 2493990. RA Murre C., McCaw P. S., Baltimore D. RT A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins RL Cell 56:777-783 (1989). RN [5]; RE0000231. RX PUBMED: 1846322. RA Sun X.-H., Baltimore D. RT An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers RL Cell 64:459-470 (1991). RN [6]; RE0000238. RX PUBMED: 1649701. RA Lassar A. B., Davis R. L., Wright W. E., Kadesch T., Murre C., Voronova A., Baltimore D., Weintraub H. RT Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo RL Cell 66:305-315 (1991). RN [7]; RE0000703. RX PUBMED: 2560751. RA Rhodes S. J., Konieczny S. F. RT Identification of MRF4: a new member of the muscle regulatory factor gene family RL Genes Dev. 3:2050-2061 (1989). RN [8]; RE0000968. RX PUBMED: 1847137. RA Chakraborty T., Brennan T., Olson E. RT Differential trans-activation of a muscle-specific enhancer by myogenic helix-loop-helix proteins is separable from DNA binding RL J. Biol. Chem. 266:2878-2882 (1991). RN [9]; RE0001484. RX PUBMED: 2797000. RA Vaidya T. B., Rhodes S. J., Taparowsky E. J., Konieczny S. F. RT Fibroblast growth factor and transforming growth factor beta repress transcription of the myogenic regulatory gene MyoD1 RL Mol. Cell. Biol. 9:3576-3579 (1989). RN [10]; RE0001507. RX PUBMED: 1695319. RA Yutzey K. E., Rhodes S. J., Konieczny S. F. RT Differential trans activation associated with the muscle regulatory factors MyoD1, myogenin, and MRF4 RL Mol. Cell. Biol. 10:3934-3944 (1990). RN [11]; RE0001620. RX PUBMED: 1850096. RA French B. A., Chow K.-L., Olson E. N., Schwartz R. J. RT Heterodimers of myogenic helix-loop-helix regulatory factors and E12 bind a complex element governing myogenic induction of the avian cardiac alpha-actin promoter RL Mol. Cell. Biol. 11:2439-2450 (1991). RN [12]; RE0002458. RX PUBMED: 2377600. RA Weintraub H., Davis R., Lockshon D., Lassar A. RT MyoD binds cooperatively to two sites in a target enhancer sequence: Occupancy of two sites is required for activation RL Proc. Natl. Acad. Sci. USA 87:5623-5627 (1990). RN [13]; RE0002654. RX PUBMED: 3175662. RA Tapscott S. J., Davis R. L., Thayer M. J., Cheng P., Weintraub H., Lassar A. B. RT MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts RL Science 242:405-411 (1988). RN [14]; RE0002661. RX PUBMED: 2174572. RA Blackwell T. K., Weintraub H. RT Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection RL Science 250:1104-1110 (1990). RN [15]; RE0002662. RX PUBMED: 1312255. RA Anthony-Cahill S. J., Benfield P. A., Fairman R., Wasserman Z. R., Brenner S. L., Stafford III W. F., Altenbach C., Hubbell W. L., DeGrado W. F. RT Molecular characterization of helix-loop-helix peptides RL Science 255:979-983 (1992). RN [16]; RE0002942. RX PUBMED: 1406681. RA Shaknovich R., Shue G., Kohtz D. S. RT Conformational activation of a basic helix-loop-helix protein (MyoD1) by the C-terminal region of murine HSP90 (HSP84) RL Mol. Cell. Biol. 12:5059-5068 (1992). RN [17]; RE0003172. RX PUBMED: 3600660. RA Olson E.N., Spizz G., Tainsky M.A. RT The Oncogenic Forms of N-ras or H-ras Prevent Skeletal Myoblast Differentiation RL Mol. Cell. Biol. 7:2104-2111 (1987). RN [18]; RE0003211. RX PUBMED: 2430720. RA Lassar A. B., Paterson B. M., Weintraub H. RT Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts into myoblasts RL Cell 47:649-656 (1986). RN [19]; RE0003212. RX PUBMED: 3690668. RA Davis R. L., Weintraub H., Lassar A. B. RT Expression of a single transfected cDNA converts fibroblasts into myoblasts RL Cell 51:987-1000 (1987). RN [20]; RE0003213. RX PUBMED: 2552320. RA Sassoon D., Lyons G., Wright W. E., Lin V., Lassar A. B., Weintraub H., Buckingham M. RT Expression of two myogenic regulatory factors myogenin and MyoD1 during mouse embryogenesis RL Nature 341:303-307 (1989). RN [21]; RE0003214. RX PUBMED: 2548731. RA Lassar A. B., Thayer M. J., Overell R. W., Weintraub H. RT Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1 RL Cell 58:659-667 (1989). RN [22]; RE0003215. RX PUBMED: 2748593. RA Weintraub H., Tapscott S. J., Davis R. L., Thayer M. J., Adam M. A., Lassar A. B., Miller A. D. RT Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD RL Proc. Natl. Acad. Sci. USA 86:5434-5438 (1989). RN [23]; RE0003216. RX PUBMED: 2546677. RA Thayer M. J., Tapscott S. J., Davis R. L., Wright W. E., Lassar A. B., Weintraub H. RT Positive autoregulation of the myogenic determination gene MyoD1 RL Cell 58:241-248 (1989). RN [24]; RE0003218. RX PUBMED: 2359457. RA Sorrentino V., Pepperkok R., Davis R. L., Ansorge W., Philipson L. RT Cell proliferation inhibited by MyoD1 independently of myogenic differentiation RL Nature 345:813-815 (1990). RN [25]; RE0003222. RX PUBMED: 1311614. RA Fuechtbauer E. M., Westphal H. RT MyoD and myogenin are coexpressed in regulating skeletal muscle of the mouse RL Dev. Dyn. 193:34-39 (1992). RN [26]; RE0003223. RX PUBMED: 1850105. RA Miner J. H., Wold B. J. RT c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation RL Mol. Cell. Biol. 11:2842-2851 (1992). RN [27]; RE0003225. RX PUBMED: 1313772. RA Li L., Chambard J. C., Karin M., Olson E. N. RT Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression RL Genes Dev. 6:676-689 (1992). RN [28]; RE0003226. RX PUBMED: 1406697. RA Carnac G., Albagli-Curiel O., Vandromme M., Pinset C., Montarras D., Laudet V., Bonnieu A. RT 3, 5, 3 - triiodothyronine positively regulates both MyoD1 gene transcription and terminal differentiation in C2 myoblasts RL Mol. Endocrinol. 6:1185-1194 (1992). RN [29]; RE0003227. RX PUBMED: 1329087. RA van Antwerp M. E., Chen D. G., Chang C., Prochownik E. V. RT A point mutation in MyoD basic domain imparts c-Myc-like properties RL Proc. Natl. Acad. Sci. USA 89:9010-9014 (1992). RN [30]; RE0003228. RX PUBMED: 1321827. RA Kim S. J., Kim K. Y., Tapscott S. J., Winokur T. S., Park K., Fujiki H., Weintraub H., Roberts A. B. RT Inhibition of protein phosphatases blocks myogenesis by first altering MyoD binding activity RL J. Biol. Chem. 267:15140-15145 (1992). RN [31]; RE0003232. RX PUBMED: 8393567. RA Thayer M. J., Weintraub H. RT A cellular factor stimulates the DNA-binding activity of MyoD and E47 RL Proc. Natl. Acad. Sci. USA 90:6483-6487 (1993). RN [32]; RE0003234. RX PUBMED: 8387507. RA Winter B., Braun T., Arnold H. H. RT cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors Myf-5 and MyoD RL J. Biol. Chem. 13:9869-9878 (1993). RN [33]; RE0003236. RX PUBMED: 8381715. RA Gu W., Schneider J. W., Condorelli G., Kaushal S., Mahdavi V., Nadal-Ginard B. RT Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation RL Cell 72:309-324 (1993). RN [34]; RE0003238. RX PUBMED: 8396258. RA Hollenberg S. M., Cheng P. F., Weintraub H. RT Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determination RL Proc. Natl. Acad. Sci. USA 90:8028-8032 (1993). RN [35]; RE0003239. RX PUBMED: 8269513. RA Rudnicki M. A., Schnegelsberg P. N. J., Stead R. H., Braun T., Arnold H. H., Jaenisch R. RT MyoD or Myf-5 is required for the formation of skeletal muscle RL Cell 75:1351-1359 (1993). RN [36]; RE0003240. RX PUBMED: 8127707. RA Muscat G. E. O., Mynett-Johnson L., Dowhan D., Downes M., Griggs R. RT Activation of MyoD gene transcription by 3, 4, 3'-triiodo-L-thyronine: a direct role for the thyroid hormone and retinoid X receptors RL Nucleic Acids Res. 22:583-591 (1994). RN [37]; RE0003241. RX PUBMED: 8120060. RA Pedraza-Alva G., Zingg J. M., Jost J. P. RT AP-1 binds to a putative cAMP response element of the MyoD1 promoter and negatively modulates MyoD1 expression in dividing myoblasts RL J. Biol. Chem. 269:6978-6985 (1994). RN [38]; RE0003242. RX PUBMED: 7958889. RA Weintraub H., Genetta T., Kadesch T. RT Tissue-specific gene activation by MyoD: determination of specificity by cis-acting repression elements RL Genes Dev. 8:2203-2211 (1994). RN [39]; RE0003244. RX PUBMED: 1330322. RA Rudnicki M. A., Braun T., Hinuma S., Jaenisch R. RT Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development RL Cell 71:383-390 (1992). RN [40]; RE0003392. RX PUBMED: 8181063. RA Ma P. C. M., Rould M. A., Weintraub H., Pabo C. O. RT Crystal structure of MyoD bHLH domain-DNA complex: perspectives on DNA recognition and implications for transcriptional activation RL Cell 77:451-459 (1994). RN [41]; RE0003393. RX PUBMED: 8479534. RA Ferre-D'Amare A. E., Prendergast G. C., Ziff E. B., Burley S. K. RT Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain RL Nature 363:38-45 (1993). RN [42]; RE0003394. RX PUBMED: 8306960. RA Ferre-D'Amare A. R., Pognonec P., Roeder R. G., Burley S. K. RT Structure and function of the b/HLH/Z domain of USF RL EMBO J. 13:180-189 (1994). RN [43]; RE0003414. RX PUBMED: 1651276. RA Weintraub H., Dwarki V. J., Verma I., Davis R. L., Hollenberg S., Snider L., Lassar A. B., Tapscott S. J. RT Muscle-specific transcriptional activation by MyoD RL Genes Dev. 5:1377-1386 (1991). RN [44]; RE0003415. RX PUBMED: 8248126. RA Fairman R., Beran-Steed R. K., Anthony-Cahill S. J., Lear J. D., Stafford III W. F., DeGrado W. F., Benfield P. A., Brenner S. L. RT Multiple oligomeric states regulate the DNA binding of helix-loop-helix proteins RL Proc. Natl. Acad. Sci. USA 90:10429-10433 (1993). RN [45]; RE0003416. RX PUBMED: 8300601. RA Shue G., Kohtz D. RT Structural and functional aspects of basic helix-loop-helix protein folding by heat-shock protein RL J. Biol. Chem. 269:2707-2711 (1994). RN [46]; RE0003417. RX PUBMED: 2236052. RA Crescenzi M., Fleming T. P., Lassar A. B., Weintraub H., Aaronson S. A. RT MyoD induces growth arrest independent of differentiation in normal and transformed cells RL Proc. Natl. Acad. Sci. USA 87:8442-8446 (1990). RN [47]; RE0003418. RX PUBMED: 1310896. RA Bengal E., Ransone L., Scharfmann R., Dwarki V. J., Tapscott S. J., Weintraub H., Verma I. M. RT Functional antagonism between c-Jun and MyoD proteins: a direct physical association RL Cell 68:507-519 (1992). RN [48]; RE0005811. RX PUBMED: 7753857. RA Vandromme M., Cavadore J.-C., Bonnieu A., Froeschle A., Lamb N., Fernandez A. RT Two nuclear localization signals present in the basic-helix 1 domains of MyoD promote its active nuclear translocation and can function independly RL Proc. Natl. Acad. Sci. USA 92:4646-4650 (1995). RN [49]; RE0012509. RX PUBMED: 8759016. RA Loveys D. A., Streiff M. B., Kato G. J. RT E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the ld3 protein RL Nucleic Acids Res. 24:2813-2820 (1996). RN [50]; RE0016247. RX PUBMED: 10629047. RA Ohneda K., Mirmira R. G., Wang J., Johnson J. D., German M. S. RT The homeodomain of PDX-1 mediates multiple protein-protein interactions in the formation of a transcriptional activation complex on the insulin promoter. RL Mol. Cell. Biol. 20:900-911 (2000). RN [51]; RE0018254. RX PUBMED: 12037571. RA Ge K., Guermah M., Yuan C. X., Ito M., Wallberg A. E., Spiegelman B. M., Roeder R. G. RT Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. RL Nature 417:563-567 (2002). RN [52]; RE0039511. RX PUBMED: 9235903. RA Anand G., Yin X., Shahidi A. K., Grove L., Prochownik E. V. RT Novel regulation of the helix-loop-helix protein Id1 by S5a, a subunit of the 26 S proteasome RL J. Biol. Chem. 272:19140-51 (1997). RN [53]; RE0048980. RX PUBMED: 9242638. RA Langlands K., Yin X., Anand G., Prochownik E. V. RT Differential interactions of Id proteins with basic-helix-loop-helix transcription factors. RL J. Biol. Chem. 272:19785-19793 (1997). RN [54]; RE0052561. RX PUBMED: 11285237. RA Mal A., Sturniolo M., Schiltz R. L., Ghosh M. K., Harter M. L. RT A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. RL EMBO J. 20:1739-1753 (2001). RN [55]; RE0042297. RX PUBMED: 10944526. RA Polesskaya A., Duquet A., Naguibneva I., Weise C., Vervisch A., Bengal E., Hucho F., Robin P., Harel-Bellan A. RT CREB-binding Protein/p300 activates MyoD by acetylation RL J. Biol. Chem. 275:34359-64 (2000). XX //